We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Exercise Controls Tumor Cell Growth Through AMPK Activation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01376583
Recruitment Status : Unknown
Verified November 2013 by Inge Holm, Rigshospitalet, Denmark.
Recruitment status was:  Recruiting
First Posted : June 20, 2011
Last Update Posted : December 2, 2013
Information provided by (Responsible Party):
Inge Holm, Rigshospitalet, Denmark

Brief Summary:
The study investigates the explanation for the positive relation found between exercise and breastcancer.

Condition or disease
Breast Cancer

Study Type : Observational
Estimated Enrollment : 10 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Running From Cancer
Study Start Date : March 2011
Estimated Primary Completion Date : December 2013
Estimated Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Biospecimen Retention:   Samples Without DNA
Bloodsamples wherefrom, serum is isolated and kept at -20 degrees celsius

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy Danish females in the age 18-30

Inclusion Criteria:

  • Healthy Females age 18-30
  • BMI 18-25
  • Regular period

Exclusion Criteria:

  • Ingestions of any hormones
  • Pregnancy
  • Chronic inflammation
  • Elite athletes

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01376583

Centre of Inflammation and Metabolism Recruiting
Copenhagen, Denmark, 2100
Contact: Grith W Højfeldt, BSc       grithwh@hotmail.com   
Principal Investigator: Grith W Højfeldt, BSc         
Sponsors and Collaborators
Rigshospitalet, Denmark
Study Director: Bente K Pedersen, Professor Centre of Inflammation and Metabolism

Responsible Party: Inge Holm, Administrator, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT01376583     History of Changes
Other Study ID Numbers: VEK-H-3-2010-141
First Posted: June 20, 2011    Key Record Dates
Last Update Posted: December 2, 2013
Last Verified: November 2013

Keywords provided by Inge Holm, Rigshospitalet, Denmark:
Breast cancer